Ascendis Pharma A/S (ASND) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 11B |
| Enterprise Value | 11.26B |
| P/E Ratio | 17.33 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 13.37 |
| Price/Book Ratio | 10.79 |
| Enterprise/Revenue | 12.95 |
| Enterprise/EBITDA | 60.17 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.74 |
| Operating Margin | 0.18 |
| Return On Assets | 0.37 |
| Return On Equity | 1.09 |
| Revenue | 691.71M |
| Revenue/Share | 18.38 |
| Gross Profit | 588.53M |
| EBITDA | -109.8M |
| Net Income | -219.03M |
| Diluted EPS | -3.62 |
| Total Cash | 964.36M |
| Total Cash/Share | 14.67 |
| Total Debt | 447.81M |
| Total Debt/Equity | 0.3 |
| Current Ratio | 2.89 |
| Book Value Per Share | 22.82 |
| 52-Week Change | 24.5 |
| 52-Week High | 282.15 |
| 52-Week Low | 188.08 |
| Moving Average 50 Days | 242.71 |
| Moving Average 200 Days | 240.32 |
| Average Volume | 739,665 |
| Shares Outstanding | 65.6M |
| % Held by Institutions | 106.08 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |